Expansion of regulatory T cells in B chronic lymphocytic leukemia: Enhanced 'brakes' on host immunity

Leukemia and Lymphoma

Volumn 50, Issue 5, 2009, Pages 687-688

  Deutsch, Varda ^a   Perry, Chava ^a   Polliack, Aaron ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CD45RO ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2; INTERLEUKIN 7 RECEPTOR; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

B LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CHRONIC LYMPHATIC LEUKEMIA; HUMAN; IMMUNE DEFICIENCY; IMMUNE DYSREGULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MEMORY T LYMPHOCYTE; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION;

CELL PROLIFERATION; HUMANS; IMMUNITY; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; T-LYMPHOCYTES, REGULATORY; TUMOR ESCAPE;

EID: 68449083231     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190902954389     Document Type: Note

References (13)

1. Curiel TJ. Tregs and rethinking cancer immunotherapy. J Clin Invest 2007;117:1167-1174.
2. LiuW, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006;203:1701-1711.
3. Zheng SG, Wang J, Wang P, Gray JD, Horwitz GA. IL-2 is essential for TGF-β to convert naïve CD4+CD257 cells to CD25+ FOXP3+ regulatory T cells and for expansion of these cells. J Immunol 2007;178:2018-2027.
4. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004;10:942-949.
5. Woo EY, Chu CS, Goletz TJ, Schlienger K, Yeh H, Coukos G, et al. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and latestage ovarian cancer. Cancer Res 2001;61:4766-4772.
6. Ichihara F, Kono K, Takahashi A, Kawaida H, Sugai H, Fujii H. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin Cancer Res 2003;9:4404-4408.
7. Sasada T, Kimura M, Yoshida Y, Kanai M, Takabayashi A. CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Cancer 2003;98:1089-1099.
8. Beyer M, Kochanek M, Darabi K, Popov A, Jensen M, Endl E, et al. Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine. Blood 2005;106:2018-2025.
9. Schreiber TH, Deyev VV, Rosenblatt JD, Podack ER. Tumorinduced suppression of CTL expansion and subjugation by gp-Ig vaccination. Cancer Res 2009;69:20026-20033.
10. Herishanu Y, Kay S, Rogowski O, Pick M, Naparstek E, Deutsch VR, et al. T-cell ZAP-70 overexpression in chronic lymphocytic leukemia (CLL) correlates with CLL cell ZAP-70 levels, clinical stage and disease progression. Leukemia 2005;19:1289-1291.
11. Porakishvili N, Roschupkina T, Kalber T, Jewell AP, Patterson K, Yong K, et al. Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (BCLL). Clin Exp Immunol 2001;126:29-36.
12. Vukmanovic-Stejic M, Zhang Y, Cook JE, Fletcher JM, McQuaid A, Masters JE, et al.Human CD4+CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest 2006;116:2423-2433.
13. Jak M, Mous R, Remmerswaal EBM, Spijker R, Jaspers A, Yagüeet A, et al. Enhanced formation and survival of CD4+CD25hiFOXP3+T cells in CLL. Leuk Lymphoma 2009;50:788-801.